NYSE:BKKT

Bakkt (BKKT) Stock Price, News & Analysis

$0.37
+0.00 (+0.87%)
(As of 01:47 PM ET)
Today's Range
$0.36
$0.38
50-Day Range
$0.36
$1.02
52-Week Range
$0.33
$2.75
Volume
1.15 million shs
Average Volume
5.59 million shs
Market Capitalization
$119.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.53

Bakkt MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
3,429.2% Upside
$13.13 Price Target
Short Interest
Bearish
16.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.17mentions of Bakkt in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$2.40 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.32) to ($0.19) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.47 out of 5 stars

Business Services Sector

221st out of 310 stocks

Nondepository Credit Institutions Industry

30th out of 47 stocks

BKKT stock logo

About Bakkt Stock (NYSE:BKKT)

Bakkt Holdings, Inc. offers software as a service and application programming interface solutions for crypto and loyalty, powering engagement, and performance. The company operates Bakkt Marketplace, a platform that enables consumers to buy, sell, and store crypto in an embedded web experience; Bakkt Crypto, a platform that supports clients with a range of crypto solutions; and Bakkt Trust, institutional-grade qualified custody solution for market participants. Its platform also offers a range of loyalty solutions, including redemption solutions for various rewards categories comprising travel, gift cards, and merchandise; travel solutions that offer a retail e-commerce booking platform, as well as live-agent booking and servicing; and unified shopping experience. The company was founded in 2018 and is headquartered in Alpharetta, Georgia.

BKKT Stock Price History

BKKT Stock News Headlines

Jim Cramer’s “The Biggest Drug Ever”
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Bakkt Announces Reverse Stock Split
Bakkt Holdings, Inc. (BKKT)
Jim Cramer’s “The Biggest Drug Ever”
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Facing delisting, Bakkt replaces its CEO
Earnings Preview: Bakkt Hldgs
Bakkt appoints Andy Main as CEO
Bakkt Announces Leadership Transition
BKKT Apr 2024 1.500 call
BKKT Apr 2024 1.500 put
BKKT Apr 2024 1.000 call
Why Crypto-Related Stock Bakkt Is Falling
Bakkt Announces Two Registered Direct Offering Agreements
See More Headlines
Receive BKKT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bakkt and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/25/2024
Today
4/26/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Nondepository credit institutions
Sub-Industry
N/A
Fax
N/A
Employees
747
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.53
High Stock Price Target
$0.75
Low Stock Price Target
$0.30
Potential Upside/Downside
+42.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-74,850,000.00
Pretax Margin
-28.89%

Debt

Sales & Book Value

Annual Sales
$780.10 million
Book Value
$0.49 per share

Miscellaneous

Free Float
315,956,000
Market Cap
$118.60 million
Optionable
Optionable
Beta
4.12
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Andrew A. Main (Age 58)
    President, CEO & Director
    Comp: $31.25k
  • Ms. Karen J. Alexander CFA (Age 52)
    CFO & Principal Financial Officer
    Comp: $661.44k
  • Mr. Marc D'Annunzio (Age 51)
    General Counsel & Secretary
    Comp: $636.68k
  • Dr. Gavin Constantine Michael (Age 59)
    Advisor
    Comp: $756.94k
  • Mr. Gordon Watson (Age 44)
    Executive Director
    Comp: $25k
  • Mr. Alex Jacobs
    Chief Administrative Officer
  • Mr. Charles Goodroe (Age 39)
    VP, Chief Accounting Officer & Principal Accounting Officer
  • Mr. Nicholas Baes
    Chief Technology Officer
  • Ms. Ann Park DeVries
    Head of Investor Relations
  • Ms. Lauren Post
    Head of Communications

BKKT Stock Analysis - Frequently Asked Questions

Should I buy or sell Bakkt stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bakkt in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BKKT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BKKT, but not buy additional shares or sell existing shares.
View BKKT analyst ratings
or view top-rated stocks.

What is Bakkt's stock price target for 2024?

2 brokers have issued 1 year target prices for Bakkt's stock. Their BKKT share price targets range from $7.50 to $18.75. On average, they predict the company's stock price to reach $13.13 in the next twelve months. This suggests a possible upside of 3,429.2% from the stock's current price.
View analysts price targets for BKKT
or view top-rated stocks among Wall Street analysts.

How have BKKT shares performed in 2024?

Bakkt's stock was trading at $55.75 at the beginning of 2024. Since then, BKKT stock has decreased by 99.3% and is now trading at $0.3719.
View the best growth stocks for 2024 here
.

Are investors shorting Bakkt?

Bakkt saw a increase in short interest in April. As of April 15th, there was short interest totaling 20,340,000 shares, an increase of 11.5% from the March 31st total of 18,250,000 shares. Based on an average daily volume of 6,010,000 shares, the days-to-cover ratio is presently 3.4 days. Approximately 16.1% of the shares of the stock are sold short.
View Bakkt's Short Interest
.

When is Bakkt's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our BKKT earnings forecast
.

How were Bakkt's earnings last quarter?

Bakkt Holdings, Inc. (NYSE:BKKT) posted its quarterly earnings data on Monday, March, 25th. The company reported ($7.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.75) by $4.50. The firm had revenue of $214.50 million for the quarter, compared to the consensus estimate of $214 million. Bakkt had a negative net margin of 9.59% and a negative trailing twelve-month return on equity of 33.06%.

When did Bakkt's stock split?

Bakkt shares reverse split on Monday, April 29th 2024. The 1-25 reverse split was announced on Tuesday, April 23rd 2024. The number of shares owned by shareholders will be adjusted after the market closes on Friday, April 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What guidance has Bakkt issued on next quarter's earnings?

Bakkt updated its FY 2024 earnings guidance on Monday, March, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.3 billion-$5.1 billion.

Who are Bakkt's major shareholders?

Bakkt's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kingswood Wealth Advisors LLC (0.04%). Insiders that own company stock include Gavin Constantine Michael, Impact Acquisition Holding Vpc, Intercontinental Exchange, Inc, Marc D'annunzio, Mark Sonbolian Elliot and Sean Roberts Collins.
View institutional ownership trends
.

How do I buy shares of Bakkt?

Shares of BKKT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BKKT) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners